Seegene Inc., a global leader in molecular diagnostics, unveiled two new technologies at ADLM 2025 in Chicago (July 29–31) ...

Upgrades to software on Bionano’s Stratys™ Compute, a server that leverages advanced GPU chips, double the number of cancer samples that can be analyzed per week and expand functionality to include ...

Discover how AVA brings scale and reproducibility to organ‑chip technology, enabling human‑relevant insights that accelerate ...

Delivered Q2 2025 revenue of $86 million Q2 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, ...

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

The global biosimulation market is set for explosive growth, with a new forecast predicting its valuation will increase from ...

As technology rapidly evolves, the integration of cutting-edge innovations in medical devices is enabling clinicians to ...

On one side, there are urgent calls to safeguard patient health information from misuse or commercial exploitation. On the ...

Traditionally, the diagnosis of Alzheimer’s disease has been based on informant interviews and clinical assessments of memory, cognition, behaviour, and mood. To increase diagnostic confidence, ...

According to the latest study from BCC Research, the "Global Microbiome Sequencing Market" is expected to grow from $1.5 ...

Impulsivity in healthy adults is linked to unhealthy dietary choices, such as higher intake of alcohol and sugary drinks and ...